GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of Arexvy (Respiratory Syncytial Virus Vaccine) when co-administered with Shingrix (Zoster Vaccine).
GSK Reports Findings on Coadministered RSV and Shingles Vaccines
Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.
GSK's RSV, Shingles vaccines show on-par immune response in joint trial
(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot together generated the same immune response in a late-stage trial as separate adminstration of the vaccines.
GSK shingles vaccine now available in Malaysia
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced the launch of its Herpes Zoster vaccine, Shingrix (MAL24056002ARZ), also known as Recombinant Zoster Vaccine, Adjuvanted (RZV) in Malaysia for the prevention of shingles (herpes zoster,
GSK Sees Positive Results in Trial of Combination RSV, Shingles Vaccine
GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older. The British pharma giant said Wednesday a Phase 3 study evaluating RSV vaccine Arexvy co-administered with Shingrix met the primary endpoint,
GSK's RSV vaccine meets main goal when co-administered with shingles shot
British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles shot, met the main goal of a late-stage trial in adults over 50 years of age.
GSK Reports Positive Data From Co-administration Of RSV And Shingles Vaccines
GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the
Armed robbery in Revesby1d
More Australians to Get Funded Shingles Vaccine
Melbourne, Australia The Government has expanded access to GSK's shingles vaccine, Shingrix, to cover individuals aged 18 ...
More Australians will be able to get a free vaccine for shingles
More Australians will be able to get a free vaccine for the painful condition shingles. Aussies ages 18 to 64 who are classed ...
What Repeat COVID Infections Do to Your Body, According to Science
Dr. Moffitt’s study above also found that the “severity of your first infection is very predictive of the severity of a ...
American States Ranked by the Highest and Lowest Vaccination Rates
Rhode Island has the highest vaccination rate across the country, while Mississippi was found to have the lowest, a new study ...
The Healthy on MSN7d
Which Vaccines Do You Need in 2024-25? Here Are Experts’ Recommendations for All Ages
Public health authorities outline who needs which vaccines, organized by age and other key variables—important information ...
You Can Get Shingles Under 50. Here’s When to Worry.
Most of us think shingles is an old person’s disease. But the reality is, it can strike at any time, triggered by ...
clinicaladvisor.com14d
Shingles Vaccine May Lower Dementia Risk, Increases Diagnosis-Free Time
Researchers conducted an observational study to compare the risk for dementia associated with both the live and recombinant shingles vaccines.
Want To Lower Your Dementia Risk? Don’t Skip This Vaccine
Additionally, Dr. Brangman says that the Tdap vaccine, which protects against tetanus, diphtheria and whooping cough, is also ...
Daily14d
CDSCO issues Cancelled Lincence List of importers
New Delhi: The Central Drugs Standard Control Organization (CDSCO) has published a list of the details of importers whose ...
bernama6d
Shingles May Cause Long-Term Pain In Older People – Expert
PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...